Recently, the news of the leaps into the Yunnan Baiyao has been like casting a giant bomb in the medical and pharmaceutical industries! The author took the first time to take stock of medical equipment leading enterprises into the big move of the pharmaceutical industry, hoping to attract the attention of medical equipment and medical people, for your reference!
Diving medical
On June 6, 2017, it spent RMB 5.638 billion to acquire a 10% stake in Baiyao Holdings. (It is worth noting that the Jiangsu Yuyue, which is a shareholder of this stock, is the company that Wu Guangming, the actual controller of Yuyue Medical, holds 95% of the shares.)
On July 13, 2015, signed the Strategic Cooperation Framework Agreement with Pfizer Investment Co., Ltd. The agreement is valid for three years. The two sides will cooperate in the field of health management of chronic diseases such as cardiovascular and cerebrovascular diseases, hypertension, research and development and use of medical and medical products, Internet health service development and Internet medicine and medical equipment sales.
In mid-April 2015, the “Strategic Framework Agreement†was signed with Ali Health. The affiliated Yuyue Medical, China Resources Wandong and Medical Cloud platforms will cooperate with Ali Health in intelligent hardware, medical imaging and hospital platforms.
The leaps and bounds in various fields are rapidly developing and the movements are constant. The cooperation with Pfizer in the past was a step into the pharmaceutical field, but it was just an introduction. Through the cooperation with Pfizer, it has accumulated an understanding of pharmaceutical companies. This shareholding has become a minority shareholder of Yunnan Baiyao, which is equivalent to a solid step in the pharmaceutical field!
For Yunnan Baiyao, this mixed system reform is a major turning point in its layout of a large health industry, which is of great significance. Accepting the leaps and shares into the stock is an important part of the layout of great health.
Based on past experience and the behavior of the fish jump, we do not expect to exclude the possibility of the company or even the wholly-owned acquisition of a pharmaceutical company in the future. We will wait and see!
Lepu Medical
On June 22, 2013, it spent 390 million yuan to acquire 60% of Henan Xinshuike Pharmaceutical Co., Ltd.
At the time, Xin Shuike had 63 drug approvals in the fields of cardiovascular, digestive and anti-infective, and the heavy product in the cardiovascular field, clopidogrel hydrogen sulfate, was the only sulfuric acid obtained after Sanofi and Xinlitai. Pharmaceutical companies that produce approvals for hydrochloropiroli tablets. The acquisition means that the tentacles of Lepu Medical have officially begun to expand into the field of pharmaceutical production.
In November 2014, it invested 576 million yuan to acquire a 51% stake in Zhejiang Xindonggang Pharmaceutical.
The main products of Zhejiang Xindonggang Pharmaceutical Co., Ltd. include the blood lipid-lowering drug atorvastatin bulk drugs and preparations. It is one of the only domestic pharmaceutical companies with the approval of atorvastatin production in China, and is also the largest in the world. One of the statin drug substance manufacturers.
On January 24, 2016, a notice was issued that it plans to spend 650 million to 120 million yuan to acquire cardiovascular-related pharmaceutical companies and hospitals.
It is reported that Lepu Medical has been committed to building a closed-loop platform for the whole industry chain of “devices + drugs + services + mobile medical care †in the cardiovascular field. Since 2014, it has carried out nearly 20 mergers or acquisitions, involving the entire industrial chain layout of the cardiovascular field. Including "20% participation in Jiangsu Youjiali Health Management Co., Ltd." and so on. In March 2015, it released the “Two App for Concentric Manager†and “Heart Managementâ€, which respectively built the Internet community of patients after stenting and the Internet community of heart failure patients constructed by intelligent heart marker detection devices.
In a hydroponic system, plants are placed in nutrient-enriched water. Mediums such as gravels, sand or vermiculite can also be used. Thus plants which are placed in the water absorb the nutrients very easly. When the nutrients from the water starts finishing , water is recycled or additional nutrients are added.
Greenhouse Garden Hydroponics,Hydroponic Garden,Hydroponic Greenhouse
JIANGSU SKYPLAN GREENHOUSE TECHNOLOGY CO.,LTD , https://www.thgreenhouse.com